Time-points for minimal residual disease monitoring in patients with acute myeloid leukemia who underwent allogeneic stem cells transplantation: a comparison between multiparameter flow cytometry and Wilm's tumor 1 expression

被引：0
|
作者：
Rossi, G. [1 ]
Carella, A. M. [1 ]
Minervini, M. M. [1 ]
di Nardo, F. [2 ]
Greco, M. M. [1 ]
Meria, E. [1 ]
Savino, L. [1 ]
de Gills, G. P. [1 ]
Di Renzo, N. [3 ]
Melpignano, A. [4 ]
Capalbo, S. [5 ]
Pisapia, G. [6 ]
Cascavilla, N. [1 ]
机构：
[1] IRCCS Casa Sollievo Sofferenza, Dept Hematol, San Giovanni Rotondo, Italy
[2] Univ Cattolica Sacro Cuore, Dept Hyg, I-00168 Rome, Italy
[3] Vito Fazzi Hosp, Dept Hematol, Lecce, Italy
[4] Perrino Hosp, Dept Hematol, Brindisi, Italy
[5] Riuniti Hosp, Dept Hematol, Foggia, Italy
[6] San Giuseppe Moscati Hosp, Dept Hematol, Taranto, Italy
来源：
BONE MARROW TRANSPLANTATION | 2015年 / 50卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P244
引用
收藏
页码：S239 / S239
页数：1
相关论文
共 50 条
  • [21] Prognostic impact of minimal residual disease analysis by flow cytometry in patients with acute myeloid leukemia before and after allogeneic hemopoietic stem cell transplantation
    Bastos-Oreiro, Mariana
    Perez-Corral, Ana
    Martinez-Laperche, Carolina
    Bento, Leyre
    Pascual, Cristina
    Kwon, Mi
    Balsalobre, Pascual
    Munoz, Cristina
    Buces, Elena
    Serrano, David
    Gayoso, Jorge
    Buno, Ismael
    Anguita, Javier
    Luis Diez-Martin, Jose
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 93 (03) : 239 - 246
  • [22] Pretransplantation minimal residual disease monitoring by multiparameter flow cytometry predicts outcomes of AML patients receiving allogeneic hematopoietic stem cell transplantation
    Zhang, Yun
    Wang, Ping
    Cassady, Kaniel
    Zou, Zhongmin
    Li, Yi
    Deng, Xiaojuan
    Yang, Wuchen
    Peng, Xiangui
    Zhang, Xi
    Feng, Yimei
    TRANSPLANT IMMUNOLOGY, 2022, 72
  • [23] Determination of minimal residual disease in patients with acute myeloid leukemia by multiparameter flow cytometry: Prognostic impact at different checkpoints
    Kern, W
    Voskova, D
    Schoch, C
    Hiddemann, W
    Schnittger, S
    Haferlach, T
    BLOOD, 2004, 104 (11) : 117A - 117A
  • [24] Persistence of minimal residual disease assessed by multiparameter flow cytometry is highly prognostic in younger patients with acute myeloid leukemia
    Ravandi, Farhad
    Jorgensen, Jeffrey
    Borthakur, Gautam
    Jabbour, Elias
    Kadia, Tapan
    Pierce, Sherry
    Brandt, Mark
    Wang, Sa
    Konoplev, Sergej
    Wang, Xuemei
    Huang, Xuelin
    Daver, Naval
    DiNardo, Courtney
    Andreeff, Michael
    Konopleva, Marina
    Estrov, Zeev
    Garcia-Manero, Guillermo
    Cortes, Jorge
    Kantarjian, Hagop
    CANCER, 2017, 123 (03) : 426 - 435
  • [25] Prognostic Value of Minimal Residual Disease Assessed By WT1 Expression Level and Flow Cytometry in Acute Myeloid Leukemia Patients Undergoing Allogeneic Marrow Transplantation
    Giannoni, Livia
    Guolo, Fabio
    Minetto, Paola
    Galaverna, Federica
    Ghiggi, Chiara
    Clavio, Marino
    Bagnasco, Samuele
    Di Grazia, Carmen
    Grasso, Raffaella
    Colombo, Nicoletta
    Avenoso, Daniele
    Pastori, Giordana
    Ballerini, Filippo
    Kunkl, Annalisa
    Miglino, Maurizio
    Lemoli, Roberto
    Gobbi, Marco
    Bacigalupo, Andrea
    BLOOD, 2014, 124 (21)
  • [26] MINIMAL RESIDUAL DISEASE BY WT1 GENE EXPRESSION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AFTER INDUCTION AND CONSOLIDATION CHEMOTHERAPY: CORRELATION WITH MULTIPARAMETER FLOW CYTOMETRY
    Franco, A.
    Kwon, M.
    Martinez-Laperche, C.
    Balsalobre, P.
    Font, P.
    Encinas, C.
    Escudero, A.
    Gayoso, J.
    Anguita, J.
    Diez-Martin, J.
    Buno, I.
    HAEMATOLOGICA, 2013, 98 : 283 - 283
  • [27] Monitoring of minimal residual disease using WT1 assay for patients with chronic myeloid leukemia who undergo allogeneic stem cell transplantation
    H Tamaki
    H Ogawa
    Bone Marrow Transplantation, 2004, 34 : 653 - 654
  • [28] Monitoring of minimal residual disease using WT1 assay for patients with chronic myeloid leukemia who undergo allogeneic stem cell transplantation
    Tamaki, H
    Ogawa, H
    BONE MARROW TRANSPLANTATION, 2004, 34 (07) : 653 - 654
  • [29] Clinical significance of minimal residual disease detected by multidimensional flow cytometry: Serial monitoring after allogeneic stem cell transplantation for acute leukemia
    Miyazaki, Takuya
    Fujita, Hiroyuki
    Fujimaki, Katsumichi
    Hosoyama, Takeshi
    Watanabe, Reina
    Tachibana, Takayoshi
    Fujita, Atsuko
    Matsumoto, Kenji
    Tanaka, Masatsugu
    Koharazawa, Hideyuki
    Taguchi, Jun
    Tomita, Naoto
    Sakai, Rika
    Fujisawa, Shin
    Kanamori, Heiwa
    Ishigatsubo, Yoshiaki
    LEUKEMIA RESEARCH, 2012, 36 (08) : 998 - 1003
  • [30] PROGNOSTIC VALUE OF MINIMAL RESIDUAL DISEASE BEFORE ALLOGENEIC MARROW TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA BY COMBINEDWT1 EXPRESSION LEVELS AND FLOW CYTOMETRY ASSESMENT
    Guolo, F.
    Minetto, P.
    Galaverna, F.
    Giannoni, L.
    Ghiggi, C.
    Clavio, M.
    Beltrami, G.
    Ibatici, A.
    Di Grazia, C.
    Raiola, A. M.
    Mitscheunig, L.
    Grasso, R.
    Colombo, N.
    De Astis, E.
    Avenoso, D.
    Cruciani, F.
    Lovera, D.
    Pastori, G.
    Ballerini, F.
    Aquino, S.
    Kunkl, A.
    Miglino, M.
    Lemoli, R. M.
    Gobbi, M.
    Carella, A. M.
    Bacigalupo, A.
    HAEMATOLOGICA, 2014, 99 : 301 - 301
12345